Bevacizumab extends survival for relapsed and advanced cervical cancer

Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center, USA
Bevacizumab extends survival for relapsed and advanced cervical cancer ( Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center, USA )
2 Jun 2013

Lapatinib in combination with chemotherapy in breast cancer

Dr J. Randolph Hecht - UCLA Medical Center, Santa Monica, USA
Lapatinib in combination with chemotherapy in breast cancer ( Dr J. Randolph Hecht - UCLA Medical Center, Santa Monica, USA )
2 Jun 2013

Comment on biennial visual inspection with acetic acid (VIA), or vinegar

Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA
Comment on biennial visual inspection with acetic acid (VIA), or vinegar ( Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA )
2 Jun 2013

Cetuximab superior to bevacizumab for advanced colorectal cancer

Dr Volke Heinemann - University of Munich Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volke Heinemann - University of Munich Munich, Germany )
1 Jun 2013

Improving outcomes of childhood neuroblastoma

Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia, USA
Improving outcomes of childhood neuroblastoma ( Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia, USA )
1 Jun 2013

Nivolumab produces long-lasting responses in patients with stage IV melanoma

Dr Mario Sznol - Yale Cancer Center, New Haven, USA
Nivolumab produces long-lasting responses in patients with stage IV melanoma ( Dr Mario Sznol - Yale Cancer Center, New Haven, USA )
1 Jun 2013

Delayed relapse of advanced ovarian cancer when treating with pazopanib

Dr Andreas du Bois - Kliniken Essen Mitte, Essen, Germany
Delayed relapse of advanced ovarian cancer when treating with pazopanib ( Dr Andreas du Bois - Kliniken Essen Mitte, Essen, Germany )
1 Jun 2013

Cetuximab superior to bevacizumab for advanced colorectal cancer

Dr Volker Heinemann - University of Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volker Heinemann - University of Munich, Germany )
1 Jun 2013

Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections

Dr Gypsyamber D’Souza - Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections ( Dr Gypsyamber D’Souza - Johns Hopkins Bloomberg School of Public Health, Baltimore, USA )
1 Jun 2013

Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer

Dr Andreas du Bois - Kliniken Essen Mitte, Germany
Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer ( Dr Andreas du Bois - Kliniken Essen Mitte, Germany )
1 Jun 2013

Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2013

Profiles of malignant GCTs and potential biomarkers for CNS germ cell tumours

Dr Matthew Murray - Cambridge Cancer Centre, UK
Profiles of malignant GCTs and potential biomarkers for CNS germ cell tumours ( Dr Matthew Murray - Cambridge Cancer Centre, UK )
29 May 2013